Targeting HER family in HER2-positive metastatic breast cancer: Potential biomarkers and novel targeted therapies - De Paula Costa Monteiro, I.; Madureira, P.; De Vasconscelos, A.; Humberto Pozza, D.; De Mello, R.A. (Pharmacogenomics, 2015)